Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide and Olaparib in MGMT-hypermethylated Colorectal Cancer
NCT04166435Phase 2Completed
- Sponsor
- Yale University
- Start
- Jun 2020
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide, olaparib in colorectal cancer (CRC), sponsored by Yale University. Started Jun 2020; status: completed.
02
Drugs
temozolomideolaparib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT04166435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04166435.